Merck & Co.
MRK • NYSE
Merck & Co. is a drug manufacturers - general company in the healthcare sector trading on NYSE, led by CEO Robert Davis, with a market cap of $303.00B.
Market Cap$303.00B
CEORobert Davis
CountryUnited States of America
Healthcare
Drug Manufacturers - General
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Merck & Co. FAQ
Common questions about Merck & Co.
Merck & Co. is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $16.0B.